Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
0(0%)
Results Posted
175%(7 trials)
Terminated
3(43%)

Phase Distribution

Ph phase_2
2
29%
Ph phase_3
3
43%
Ph phase_4
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
3(42.9%)
Phase 4Post-market surveillance
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(3)

Detailed Status

Completed4
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
57.1%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (28.6%)
Phase 33 (42.9%)
Phase 42 (28.6%)

Trials by Status

terminated343%
completed457%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_3

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique

NCT01297465
completedphase_3

Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)

NCT01154192
terminatedphase_3

A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

NCT01497197
terminatedphase_2

AS900672-Enriched in Ovulation Induction

NCT00553514
completedphase_2

Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)

NCT00505752
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT01297465Phase 3

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique

Completed
NCT01154192Phase 3

Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)

Completed
NCT01497197Phase 3

A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

Terminated
NCT00553514Phase 2

AS900672-Enriched in Ovulation Induction

Terminated
NCT00505752Phase 2

Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)

Completed
NCT01339299Phase 4

Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)

Completed
NCT00328926Phase 4

Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7